New Hope in War Against Cystic Fibrosis • Chinese Man With
Total Page:16
File Type:pdf, Size:1020Kb
www.asiabiotech.com Research News Australia Korea Australia Finds New Chinese Man with Hope in Treating Cystic Transplanted Hands Cuts Fibrosis His Birthday Cake Australian researchers have found a way of A young man, who has fully recovered after receiving preventing the stubborn bacterial biofilms that clog an allogeneic transplant of two hands, has recently marked the lungs of people with cystic fibrosis and eventually his 20th birthday in a hospital in Harbin, the capital city cause their deaths. They hope their research will of northeast China’s Heilongjiang province. improve the survival rates of people with this Mr. Gao Liang, the patient, cut the cake with his new common genetic disease and also improve infection hands and handed out pieces to doctors and nurses in the control in hospitals. Faculty of Clinical Medicine of Harbin Medical University, About 2500 Australians have cystic fibrosis, a where he received the transplant in January last year. disease characterized by a build up of thick mucus in the lungs and pancreas leading to breathing Dr. Zhang Xinying said that it is no mean feat for Mr. difficulties and nutritional problems. Gao to cut the cake with his hands, adding that it proves that the functions of his hands have virtually recovered. The lungs of most victims also become infected with the bacteria pseudomonas aeruginosa, a Mr. Gao said that he can now brush his teeth, wash persistent and chronic infection causing his face, comb his hair and put on his clothes with his inflammation and damage to lung tissue. But new hands. He said that he is happy and even won in an researchers from Brisbane’s Institute of Molecular arm wrestling bout at his party. Bioscience have found that the severity of these Severe frostbite caused him to lose his hands and legs. bacterial infections can be reduced or even prevented He had artificial legs fitted in another hospital. According by using an enzyme that breaks down DNA. to medical records, Mr. Gao’s case is the fourth successful Dr. John Mattick, co-director of the institute, one in the world and the second in Asia. said, “During lung infection pseudomonas aeruginosa creates a biofilm, a soup rich in proteins, Compared with heart transplants and other single complex sugars and DNA. This biofilm plays a vital organ transplants, hand transplants are much more role in establishing bacterial colonies that are also complicated, involving even more systems and tissues such resistant to antibiotics and the host’s immune as skin, tendons, blood vessels, nerves and bone marrow. response.” He said, “Scientists have known for a These lead to very low success rate of such trasplantation. while that the biofilm of this pathogen has a high The development of advanced medical technology DNA content. Our research showed that treating the biofilm with an enzyme called dnaseI, which breaks to reforge human limbs and reduce immunological down DNA into its component molecules, destroys rejection has made hand transplants a reality. the biofilm and restricts the establishment of One year of close observation showed that Mr. Gao infectious colonies.” suffers no side effects from the medicines he took to prevent Dr. Cynthia Whitchurch, a molecular biologist immunological rejection, and the nerves of his hand grow at the institute, said that pseudomonas infections by 3 mm daily. Mr. Gao now takes a much smaller dose caused the death of about 95 percent of people with of medicine compared with other people who have cystic fibrosis. Ideally, the DNA-destroying enzyme transplanted hands. would be used to prevent pseudomonas infections occurring. To date, ten similar operations have been completed But, so far, research has been done only in test in the world, seven of which are performed by Chinese tubes and clinical trials are still some way off. Dr. doctors. Among the total population of 1.3 billion, China Whitchurch said that the DNA-destroying enzyme currently has more than 8.5 million people with deformed could also have other applications. limbs. 154 APBN • Vol. 6 • No. 5 • 2002 v6n5-pt2 154 3/7/02, 11:10 AM Research News publication in the journal Science. Dr. Rod Wing, China Reveals Rice director of the Clemson University Genomics Institute Genome Sequence and the former US representative to the IRGSP, said, “Rice is the rosetta stone for cereals. The world Marking a milestone in plant-genomics research, population will double in 50 years. We have to know scientists in China have made public a sequence of a everything we can about the most important food crop widely grown rice strain that has never before been in the world. Knowing this sequence now will accelerate sequenced. The results of the indica strain sequence everything. Understanding indica together with the was presented to the 10th Annual Plant, Animal & anticipated public release of japonica will also allow Microbe Genomes Conference held in Beijing by the research not possible with only one genome alone.” Beijing Genomic Institute (BGI). Dr. Ed Kaleikau, director of the plants division at the US Department of Agriculture, said, “Rice is a model The sequencing effort of the indica strain for all cereal plants. Its sequencing will lead to the yielded 386 million base pairs in a six-fold identification of genes not only important in rice but in coverage, and an initial analysis showed that other cereals. Eventually it will lead to a better the genome contains approximately 60 000 understanding of rice and all cereal crops including to 65 000 genes. wheat, barely and corn. For important plants, this could be compared to the sequencing of the human genome. The Oryza sativa indica strain, which accounts for A better understanding of plant biology is now available the majority of rice grown in China, has never before for the second largest plant kingdom.” been sequenced. Preliminary results of the BGI project, begun in May 2000 and completed in October 2001, was published in the Chinese Science Bulletin when its draft was complete. However, the extent of the work remained virtually unknown outside a cadre of Chinese genomics researchers until the team presented their Shanghai Cancer Survey findings during the conference. Seeks Effective Treatments According to Dr. Jun Yu, a member of the team, BGI researchers sequenced the indica strain using a A large-scale survey among cancer sufferers is to whole genome shotgun approach. The effort yielded be carried out in Shanghai as medical chiefs seek more 386 million base pairs in a six-fold coverage, and an effective treatments for the debilitating disease. Starting initial analysis by BGI researchers showed that the in March, the survey will be conducted among 10 000 genome contains approximately 60 000 to 65 000 cancer patients in Shanghai and its neighboring cities. genes. Currently, the organizers, Shanghai Cancer The effort, which independent researchers are only Recovery Club, Shanghai University of Traditional now beginning to analyze, is the first rice genome to be Chinese Medicine and Shanghai Green Valley released to the public. Last January, Syngenta and Corporation, are enrolling volunteers and patients Myriad Genetics announced the draft sequencing of the willing to participate in the survey. japonica strain, but the companies have yet to release Dr. Yuan Zhengping, director of the club, said, “The those data. survey will follow each participating patient for a year. An international public consortium, the Such a large-scale survey is unprecedented in China.” International Rice Genome Sequencing Project (IRGSP), The survey will be composed of questions on non- is set to finish its own sequence of the japonica genome medical methods (such as physical training and by the end of 2002. The IRGSP, which includes the US, attitudes) in determining their contribution to the Japan, and China, is performing the sequence using the recovery of cancer patients. Other questions will center BAC by BAC approach which when compared with around the importance of social support and family whole-genome shotgun sequencing is more time- care, and the relationship between C-type character intensive. (reserved, unwilling to vent their unhappiness) and The Chinese sequencing data are under review for cancer cells. APBN • Vol. 6 • No.5 • 2002 155 v6n5-pt2 155 3/7/02, 11:10 AM www.asiabiotech.com Research News Statistics show that the incidence of cancer in was reduced, the authors suggest that the immune Shanghai is among the highest in China. systems of the mice may not be able to fight off infection. Every year, 43 000 local residents fall victim to the The authors caution that the factors affecting clone disease, of whom 34 000 resulted in death. And this longevity are many and subtle, including genetic figure is continuing to rise. Research has found that the background and the type of cell from which the nucleus majority of Chinese cancer patients survive during is taken — the so-called donor cell. operations, radiotherapy or chemotherapy. Instead, they Dr. Ogura said, “There may be reprogramming error succumb while recuperating after routine hospital which may have unpredictable effects in the long run.” treatment. Dr. Yuan said, ‘’How to help them better Reprogramming error is thought to occur when a cell recover after receiving routine treatment in hospital is already assigned to a bodily task — in this case in the of vital importance to cancer patients.” testis — is “reset” in preparation for cloning and development into an embryo. Japan “This study reinforces the opinion expressed by many that clones are not entirely normal and that we should be careful about how we use this technology,” said Dr. David Solter, a biologist at the Max Planck Tokyo Scientists Find Institute of Immunobiology in Freiburg, Germany, who Cloned Mice Have Shorter is not involved in the Japanese study.